ATLANTA, GA – – (May 16, 2018) – – Holzer & Holzer, LLC is investigating whether Evolus, Inc. (“Evolus” or the “Company”) (NASDAQ: EOLS) complied with the federal securities laws.  On May 16, 2018, Evolus announced that the FDA sent a Complete Response Letter related to the Company’s Biologics License Application for DWP-450, a developmental treatment of frown lines. The FDA’s Complete Response Letter noted deficiencies in Evolus’ Chemistry, Manufacturing and Controls processes. The price of Evolus stock fell following the announcement. If you purchased Evolus common stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Alexandria P. Rankin, Esq. at arankin@holzerlaw.com, or call the firm by toll-free telephone at (888) 508-6832.

Provide Your Information To Take Action

  • Plaintiff Certifies That:
    1. Plaintiff has reviewed the complaint and authorized its filing.
    2. Plaintiff did not acquire the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this private action or any other litigation under the federal securities laws.
    3. Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.
    4. Plaintiff represents and warrants that he/she/it is fully authorized to enter into and execute this certification.
    5. Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond the Plaintiff's pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the class as ordered or approved by the court.
    6. Plaintiff has made no transaction(s) during the Class Period in the debt or equity securities that are the subject of this action except those set forth below:
  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
    Add a new row
  • Date SoldNumber of Shares SoldSelling Price Per Share 
    Add a new row
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.